Program
Welcome and Opening Words
Ouli Uimonen, CEO of Pharmaca Health Intelligence
Welcome to the MORNING SESSION: Explore the potential of artificial intelligence in healthcare. Delve into predictions and trends that define the future landscape of AI. Discover real-world case studies showcasing the integration of AI to optimize medication treatments and enhance their effectiveness.
The session is hosted by Lauri Kuronen, CEO, VEIL.AI Denmark ApS
KEYNOTE: The Present and Future of Artificial Intelligence
Hannu Toivonen, Professor of Computer Science, University of Helsinki
- What is AI and how does it work?
- The effects of AI on society and technology
- How is artificial intelligence expected to develop in the coming years?
- What risks are associated with it?
- Is there consideration for restricting the use of artificial intelligence?
AI in Nordic Healthcare: where we are today and how to accelerate
Joona Pylkäs, Head of Data and AI, Tietoevry Care
Data and AI driven transformation of pharmaceutical R&D – case Orion
Sammeli Liikkanen, Director, Digital Medicine at Orion Corporation
AI Use Cases in Healthcare
Mikko Kytö, Development Manager at Helsinki University Central Hospital, IT management
Welcome to the AFTERNOON SESSION! Explore the groundbreaking transformations in healthcare driven by Real-World Evidence (RWE). Gain an understanding of the RWE ecosystem in the Nordics and its significance in decision-making processes.
The session is hosted by Erkki Soini, CEO at ESiOR, Chairman at Kuopio Health
ONLINE KEYNOTE: Digital transformation, boosted by AI, as a driving force in reinventing healthcare
Nasim Farrokhnia, MD, PhD, MBA, Healthcare Executive, Microsoft Global Healthcare and Life Sciences Team
The European Health Data Space
Markus Kalliola, Project Director, Sitra
FinOMOP: A harmonized health data network
Tarja Laitinen, Director of Research
Will RWE ever kick RCTs out of HTAs?
Rafael Rodrigo, Key Account Manager, Swedish Pharma Insights
How to facilitate clinical trials using external data sources, case Bayer
Jussi Leinonen, Strategic Project Lead, Bayer
Summary and end of the official part of the Event
Erkki Soini
